The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global nitinol medical devices market size reached US$ 16.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 25.7 Billion by 2027, exhibiting a growth rate (CAGR) of 7.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Nitinol belongs to a class of shape memory alloys (SMA) made using equal concentrations of nickel and titanium. It is a super elastic material with the ability of phase transformation from austenite to martensite and back to the stress-free austenite state. It is widely used to develop medical devices that undergo repetitive deformations from high strain levels during deployment. Some of the commonly used nitinol medical devices include catheter tubes, guidewires, stone retrieval baskets, filters, needles, dental files, arch wires, and other surgical instruments. At present, these medical devices find extensive applications in minimally invasive (MI) procedures around the world.
There is a significant increase in the prevalence of chronic and cardiovascular diseases worldwide on account of sedentary lifestyles and the rising number of individuals who consume alcohol excessively and smoke. This, in confluence with the growing geriatric population, which is more susceptible to medical ailments, represents one of the key factors driving the market. Apart from this, the increasing adoption of minimally invasive surgeries (MIS) on account of its numerous benefits, including smaller incisions, less scarring, considerable accuracy, and decreased risk of complications, is positively influencing the utilization of nitinol medical devices across the globe. Furthermore, leading manufacturers are introducing advanced nitinol medical devices like peripheral vascular stents that find extensive applications in general surgery, structural heart diseases, and orthopedics. They are also focusing on developing material technology to offer better radiopacity, higher strength, enhanced purity, and tighter transformational hysteresis, which is creating a favorable market outlook. Other major factors, including the introduction of biodegradable polymer stents and growing applications of nitinol medical devices in orthodontics and endodontics, are anticipated to fuel the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nitinol medical devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application and end user.
Breakup by Product Type:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Endosmart GmbH, Medtronic plc, Shanghai MicroPort Medical (Group) Co. Ltd., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates Inc. and Zimmer Biomet.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Arthrex Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Endosmart GmbH, Medtronic plc, Shanghai MicroPort Medical (Group) Co. Ltd., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates Inc. and Zimmer Biomet|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at